Budget And Draft Roadmap Discussed In Revamp Of EU Medtech Database
This article was originally published in Clinica
The European Commission's newly-established steering committee tasked with developing the next phase of the EU medical device database, ie EUDAMED III, underlined the importance of ensuring that "enough budget and resources" are allocated to the database, among other issues, at its first ever meeting on Jan 19.
You may also be interested in...
An independent audit of the new EU Clinical Trials Information System has finally commenced, indicating that plans are on track for the EU Clinical Trial Regulation to be implemented from December 2021.
EU regulators have agreed on supplementary pharmacovigilance requirements applicable to COVID-19 vaccines following approval.
The UK Medicines and Healthcare products Regulatory Agency wants clinical trial sponsors to integrate available regulatory flexibilities into normal practice so that their studies can withstand further potential disruptions from the COVID-19 pandemic.